Daiwa Securities Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9
| Closed | – | – | 1346 |
|
|
2023
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 1307 |
|
|
2023
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 1327 |
|
|
2023
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 1251 |
|
|
2022
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 1335 |
|
|
2022
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1287 |
|
|
2022
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 1283 |
|
|
2022
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 1306 |
|
|
2021
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 1335 |
|
|
2021
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1268 |
|
|
2021
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 1194 |
|
|
2021
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 1205 |
|
|
2020
Q4 | $2K | Sell |
9
-19
| -68% | -$4.22K | ﹤0.01% | 1121 |
|
|
2020
Q3 | $6K | Buy |
28
+4
| +17% | +$857 | ﹤0.01% | 1066 |
|
|
2020
Q2 | $7K | Hold |
24
| – | – | ﹤0.01% | 1072 |
|
|
2020
Q1 | $7K | Hold |
24
| – | – | ﹤0.01% | 1070 |
|
|
2019
Q4 | $7K | Sell |
24
-2
| -8% | -$583 | ﹤0.01% | 1077 |
|
|
2019
Q3 | $4K | Hold |
26
| – | – | ﹤0.01% | 1076 |
|
|
2019
Q2 | $2K | Buy |
26
+9
| +53% | +$692 | ﹤0.01% | 1130 |
|
|
2019
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 1119 |
|
|
2018
Q4 | $2K | Hold |
17
| – | – | ﹤0.01% | 1092 |
|
|
2018
Q3 | $4K | Hold |
17
| – | – | ﹤0.01% | 1076 |
|
|
2018
Q2 | $4K | Hold |
17
| – | – | ﹤0.01% | 1096 |
|
|
2018
Q1 | $4K | Buy |
+17
| New | +$4K | ﹤0.01% | 1079 |
|